|
20 Sep 2025 |
Navin Fluorine
|
Consensus Share Price Target
|
4793.80 |
5141.37 |
- |
7.25 |
hold
|
|
|
|
|
10 May 2021
|
Navin Fluorine
|
ICICI Securities Limited
|
4793.80
|
3460.00
|
3213.35
(49.18%)
|
Target met |
Hold
|
|
|
The company has been undertaking a capex of | 195 crore for the speciality chemical segment along with HPP plant with a capex of | 436 crore already in construction. The asset turn is expected to be around 1.3-1.5x. This would entail strong growth for high value segment. In turn, this translates into higher gross margins and thereby operational performance. We also expect that since the company is already working on more than 20 molecules for speciality chemical segment, this should support double digit revenue growth for the segment. Further, higher utilisation for CRAMS should...
|
|
28 Jan 2021
|
Navin Fluorine
|
ICICI Securities Limited
|
4793.80
|
2820.00
|
2344.25
(104.49%)
|
Target met |
Hold
|
|
|
Navin Fluorine reported topline growth of 19% YoY to | 309 crore against our estimate of | 305 crore. The growth was largely led by the CRAMS, speciality chemical segments, which were up 51% YoY, 26% YoY to | 71 crore, | 122 crore, respectively. Revenue from inorganic fluoride remained higher by 12% YoY to | 57 crore while the same from refrigerant was down 18% YoY to | 47 crore. Despite the value added segments, revenue remained higher compared to legacy business. Gross margins for the quarter fell 342 bps YoY to 53.9%, leading to lower than expected EBITDA...
|
|
17 Dec 2020
|
Navin Fluorine
|
ICICI Securities Limited
|
4793.80
|
3040.00
|
2555.90
(87.56%)
|
Target met |
Buy
|
|
|
Navin Fluorine has outlined capital expenditure for setting up a multipurpose plant (MPP) with an outlay of | 195 crore. The capex will be undertaken by its wholly owned subsidiary, Navin Fluorine Advanced Sciences Ltd at Dahej, Gujarat. The new capacity is expected to come on stream during H1FY23 and will create opportunities for new products in life science and crop science sectors in the specialty chemicals business. The company has already identified potential 12 new products of which five are going to be commercialised initially, which find application in crop protection. This new capacity would retain a mix of 50:50 among life science...
|
|
17 Dec 2020
|
Navin Fluorine
|
Edelweiss
|
4793.80
|
2817.00
|
2621.20
(82.89%)
|
Target met |
Buy
|
|
|
Navin Fluorine International Ltd (NFIL) has announced capex of INR195cr to set up a multi-purpose plant (MPP) for its Specialty Chemicals business at Dahej
|
|
02 Nov 2020
|
Navin Fluorine
|
Edelweiss
|
4793.80
|
2394.00
|
2178.60
(120.04%)
|
Target met |
Buy
|
|
|
Navin Fluorine International Ltd (NFIL) delivered a strong performance in Q2FY21.
|
|
30 Oct 2020
|
Navin Fluorine
|
Dolat Capital
|
4793.80
|
2463.00
|
2318.90
(106.73%)
|
Target met |
Accumulate
|
|
|
Navin Fluorine International Ltd (NFIL IN) reported a stellar 2QFY21 performance. Sales/EBITDA/PAT beat our estimates as Sales grew by 16.8% YoY to Rs 3.19bn (D.est: Rs 2.56bn)....
|
|
09 Oct 2020
|
Navin Fluorine
|
ICICI Securities Limited
|
4793.80
|
2550.00
|
1977.25
(142.45%)
|
Target met |
Buy
|
|
|
|
|
25 Jun 2020
|
Navin Fluorine
|
Edelweiss
|
4793.80
|
1837.00
|
1557.50
(207.79%)
|
Target met |
Buy
|
|
|
Navin Fluorine International Ltd (NFIL) is a pure-play fluorochemical company in India, with a significant focus on research and development.
|
|
23 Jun 2020
|
Navin Fluorine
|
Way2Wealth
|
4793.80
|
|
1557.50
(207.79%)
|
|
Not Rated
|
|
|
Navin Fluorine International Ltd (NFIL) reported a topline growth of ~9.5% YoY to `2766mn on the back of robust growth in its segments such as specialty chemicals and CRAMS which surged by ~52% & ~26% YoY respectively in Q4FY20. Specialty Chemicals recorded higher growth due to strong performance in domestic & export markets driven by higher volumes and CRAMS business due to its strong order book position in Q4FY20. However, the robust performance in mentioned segments was offset...
|
|
18 Jun 2020
|
Navin Fluorine
|
Dolat Capital
|
4793.80
|
1657.00
|
1594.75
(200.60%)
|
Target met |
Buy
|
|
|
Navin Fluorine reported in-line standalone Sales at Rs 2.65bn, up by 8.5% YoY (D.est: Rs 2.61bn). EBITDA grew by 28.7% YoY to Rs 672mn. Reported PAT stood at Rs 2.68bn owing to a favorable court order from the IT appellate tribunal pertaining to its case related to classification of receipts on account of Certified Emission Reduction (CER) as capital receipts not chargeable to tax from financial year 2007-08 to financial year 2012-13. NFIL witnessed a strong gross margin expansion of 426 bps YoY to...
|